Sort
16,300 grants matching “fatty liver disease”
Impact of NAFLD on Metabolic Brain Function via CEST MRI in HIV-Positive Individuals
$539,000Md Nasir Uddin · University Of Rochester · DP1 · FY2024 · DK
Impact of NAFLD on Metabolic Brain Function via CEST MRI in HIV-Positive Individuals
$539,000Md Nasir Uddin · University Of Rochester · DP1 · FY2025 · DK
Axin Stabilization by Novel Small Molecules to Treat Non-alcoholic Steatohepatitis
$538,952Yan Shu · University Of Maryland Baltimore · R01 · FY2023 · DK
Gene-by-diet interactions in metabolic syndrome traits
$538,896Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2017 · HL
Gene-by-diet interactions in metabolic syndrome traits
$538,896Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2016 · HL
Gene-by-diet interactions in metabolic syndrome traits
$538,896Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2019 · HL
Role of Screening and Early Intervention in Primary Care with Low-Dose Pioglitazone for Patients with T2DM and NASH
$538,644Kenneth Cusi · University Of Florida · R01 · FY2023 · DK
Novel Pathways of Cellular Cholesterol Efflux
$538,613Alan Richard Tall · Columbia University Health Sciences · P01 · FY2007 · HL
Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human Primates
$538,512Gerald I Shulman · Yale University · R01 · FY2020 · DK
Liver Parametric PET
$538,373Guobao Wang · University Of California At Davis · R01 · FY2022 · DK
Role of liver fat and fibrosis in human CVD risk phenotypes.
$538,353Rohit Loomba · University Of California, San Diego · P01 · FY2023 · HL
AGE-induced Phenotype of the Retinal Pigment Epithelium
$538,286James T Handa · Johns Hopkins University · R01 · FY2009 · EY
Investigating a master regulator of large intestine stem cells
$538,260Qiao Joe Zhou · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · DK
Non Alcoholic Steatohepatitis Clinical Research Network
$538,178Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2019 · DK
QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload
$538,134Yi Wang · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · DK
Small molecule antagonists targeting EphB receptors for the treatment of nonalcoholic steatohepatitis (NASH)
$538,034Patrice Mimche · University Of Utah · R01 · FY2024 · DK
Alpha and Beta Cell Function in Normal and Diabetic Man
$537,960John E Gerich · University Of Rochester · R01 · FY2007 · DK
An NADH-ChREBP axis in fatty liver disease and dyslipidemia
$537,842Russell Paul Goodman · Massachusetts General Hospital · R01 · FY2023 · DK
Genetic Regulation of Nonalcoholic Fatty Liver Disease
$537,831Marisa Wong Medina · University Of California, San Francisco · R01 · FY2024 · DK
Small molecule allosteric inhibitors of PCSK9 processing to phenocopy cardioprotective genetic variants.
$537,538John S Chorba · University Of California, San Francisco · R61 · FY2023 · HL
Spinal cord injury causes liver pathology and metabolic dysfunction
$537,485Dana M McTigue · Ohio State University · R01 · FY2023 · DK
Spinal cord injury causes liver pathology and metabolic dysfunction
$537,485Dana M McTigue · Ohio State University · R01 · FY2025 · DK
Spinal cord injury causes liver pathology and metabolic dysfunction
$537,485Dana M McTigue · Ohio State University · R01 · FY2022 · DK
RNA modification in cardiometabolic disease
$537,319Tamer Sallam · University Of California Los Angeles · R01 · FY2024 · DK
Preventing Diabetes in Latino Youth
$537,179Gabriel Quantum Shaibi · Arizona State University-Tempe Campus · R01 · FY2020 · DK